Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07603193 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib Cream

Study acronym: REACHED
StatusEnrolling by Invitation
PhaseNot specified
SponsorLEO Pharma
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this non-interventional study is to assess changes in the signs and symptoms of Chronic Hand Eczema (CHE), as well as the safety profile and use of delgocitinib cream in routine clinical practice, over a 52-week observation period. The main question it aims to answer is: Does delgocitinib cream show effectiveness in routine clinical practice in adult patients with moderate to severe Chronic Hand Eczema (CHE), as measured by achievement of a modified Physician Global Assessment (mPGA) score of 0 or 1? The decision to prescribe delgocitinib cream is made by the treating physician, as part of the participant's routine medical care for CHE.
Trial Details
NCT Number NCT07603193
Lead Sponsor LEO Pharma
Collaborators: Optimapharm, ICON Clinical Research, IQVIA Inc., Vivactis M2Research
Conditions
(from sponsor)		 Chronic Hand Eczema (CHE)
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov